File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0025045046
- PMID: 2144405
- WOS: WOS:A1990DY99700042
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Possible modulation of release of atrial natriuretic factor by endothelium-derived relaxing factor
Title | Possible modulation of release of atrial natriuretic factor by endothelium-derived relaxing factor |
---|---|
Authors | |
Keywords | endocardium guanosine 3',5'-cyclic monophosphate isolated rat atrium |
Issue Date | 1990 |
Publisher | American Physiological Society. The Journal's web site is located at http://ajpcon.physiology.org/ |
Citation | American Journal Of Physiology - Heart And Circulatory Physiology, 1990, v. 259 n. 3 28-3, p. H982-H986 How to Cite? |
Abstract | The aim of the present study was to investigate the influence of inhibitors of endothelium-dependent relaxing factor on the release of atrial natriuretic factor from isolated rat atria. Electrical stimulation of the tissue produced a frequency-dependent increase in secretion of atriopeptide from basal levels. Saponin (0.3 mg/ml for 45 min) augmented the basal release of the peptide. Methylene blue (10-5 M), oxyhemoglobin (10-6 M), or hydroquinone (10-5 M), agents that inhibit the effects of endothelium-derived relaxing factor by different mechanisms, caused an increase in the basal secretion of atrial natriuretic factor. Blockade of cyclooxygenase with indomethacin (10-5 M) did not alter the release of atriopeptide, suggesting that it is not controlled by endogenous prostaglandins. These results would be explained if the inhibitors tested were to interfere with a factor released continuously from either endocardial cells or endothelial cells of the atrial blood vessels and having the same nature as endothelium-derived relaxing factor. Such release may exert a tonic negative modulatory influence on the secretion of atrial natriuretic factor. |
Persistent Identifier | http://hdl.handle.net/10722/170973 |
ISSN | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | SanchezFerrer, CF | en_US |
dc.contributor.author | Burnett Jr, JC | en_US |
dc.contributor.author | Lorenz, RR | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:11:40Z | - |
dc.date.available | 2012-10-30T06:11:40Z | - |
dc.date.issued | 1990 | en_US |
dc.identifier.citation | American Journal Of Physiology - Heart And Circulatory Physiology, 1990, v. 259 n. 3 28-3, p. H982-H986 | en_US |
dc.identifier.issn | 0002-9513 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/170973 | - |
dc.description.abstract | The aim of the present study was to investigate the influence of inhibitors of endothelium-dependent relaxing factor on the release of atrial natriuretic factor from isolated rat atria. Electrical stimulation of the tissue produced a frequency-dependent increase in secretion of atriopeptide from basal levels. Saponin (0.3 mg/ml for 45 min) augmented the basal release of the peptide. Methylene blue (10-5 M), oxyhemoglobin (10-6 M), or hydroquinone (10-5 M), agents that inhibit the effects of endothelium-derived relaxing factor by different mechanisms, caused an increase in the basal secretion of atrial natriuretic factor. Blockade of cyclooxygenase with indomethacin (10-5 M) did not alter the release of atriopeptide, suggesting that it is not controlled by endogenous prostaglandins. These results would be explained if the inhibitors tested were to interfere with a factor released continuously from either endocardial cells or endothelial cells of the atrial blood vessels and having the same nature as endothelium-derived relaxing factor. Such release may exert a tonic negative modulatory influence on the secretion of atrial natriuretic factor. | en_US |
dc.language | eng | en_US |
dc.publisher | American Physiological Society. The Journal's web site is located at http://ajpcon.physiology.org/ | en_US |
dc.relation.ispartof | American Journal of Physiology - Heart and Circulatory Physiology | en_US |
dc.subject | endocardium | - |
dc.subject | guanosine 3',5'-cyclic monophosphate | - |
dc.subject | isolated rat atrium | - |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Atrial Natriuretic Factor - Metabolism | en_US |
dc.subject.mesh | Electric Stimulation | en_US |
dc.subject.mesh | Heart Atria | en_US |
dc.subject.mesh | Hydroquinones - Pharmacology | en_US |
dc.subject.mesh | Indomethacin - Pharmacology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Methylene Blue - Pharmacology | en_US |
dc.subject.mesh | Myocardium - Metabolism | en_US |
dc.subject.mesh | Nitric Oxide - Antagonists & Inhibitors - Physiology | en_US |
dc.subject.mesh | Oxyhemoglobins - Pharmacology | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, Inbred Strains | en_US |
dc.title | Possible modulation of release of atrial natriuretic factor by endothelium-derived relaxing factor | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 2144405 | - |
dc.identifier.scopus | eid_2-s2.0-0025045046 | en_US |
dc.identifier.volume | 259 | en_US |
dc.identifier.issue | 3 28-3 | en_US |
dc.identifier.spage | H982 | en_US |
dc.identifier.epage | H986 | en_US |
dc.identifier.isi | WOS:A1990DY99700042 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | SanchezFerrer, CF=7006646703 | en_US |
dc.identifier.scopusauthorid | Burnett Jr, JC=35391042200 | en_US |
dc.identifier.scopusauthorid | Lorenz, RR=7402095192 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0002-9513 | - |